Ikena Oncology
Dr. Tabernero currently serves as Head of the Medical Oncology Department at the Vall d’Hebron Barcelona Hospital and the Director of the Vall d’Hebron Institute of Oncology. His research group aims at potentiating molecular therapies targeting specific oncoproteins and accelerating more effective personalized cancer medicines for patients displaying genetic lesions or pathway dysregulation. Dr. Tabernero has held leadership positions in many other organizations devoted to advancing cancer research, including Past President of the European Society for Medical Oncology (ESMO) from 2018-2019. He holds MD and PhD degrees from the Universitat Autònoma de Barcelona, Spain.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ikena Oncology
Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.